Towards An Understanding of the Role of Genetics in Determining Future Treatment Options in Advanced Prostate Cancer – SLCO2B1 and SLCO1B3

We have heard for a period of time that the future of cancer treatment is in genetics. Despite the hubbub, we see very little hard evidence of this in today’s current treatment decisions. Treatment still remains tied into protocols with a strong bias to following a common map. Each map does have little variances, but [...]

Prostate Cancer Survivors Should be Prescribed Exercise

According to a report released recently by the UK charity Macmillan Cancer Support exercise can benefit cancer survivors, including prostate cancer survivors. This report disproves the theory that those suffering with cancer or who have beaten the disease should simply rest. Rest no more, exercise should be prescribed to those at all stages of cancer [...]

Clinical Trials for Prostate Cancer: Myths & Facts

Clinical trials are important both for your treatment and for the purpose of advancing our knowledge about drugs and treatments against prostate cancer. The treatment of advanced and recurrent prostate cancer has made significant steps over the last 2 years, but without the active participation of all of us our progress will be slowed, perhaps [...]

Important Agent Orange Information for Those Who Served in Thailand

The United States Veterans Administration (VA) has announced that, like those who served in Vietnam, veterans who served in Thailand maybe be entitled to VA benefits. Those who had served at one of the military bases in Thailand listed in the below URL and the locations at those bases identified, and experiencing any of the [...]

Using Zytiga Prior to Chemotherapy, Is It A Good Idea?

It is interesting that Dr. S. Meyers just produced a video on the issue of using the newly approved drug Zytiga (abiraterone acetate) prior to chemotherapy instead of post-chemotherapy. I find it interesting because like him, I have been receiving a number of questions about this same issue. […]

Go to Top